Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000402

Drug Information
NameDemeclocycline    
SynonymsSPBio_002705; KBioGR_000926; NCGC00162149-04; (2Z,4S,4aS,5aS,6S,12aS)-2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; SAM002589921; (4S,4aS,5aS,6S,12aS)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; DMCT; DMCTC; Demeclocycline [USAN:BAN]; Novotriclina; CID5311063; SMP1_000091; NCGC00015359-01; Spectrum3_000378; CHEMBL1591; RP 10192; CID5281009; 7-Chloro-4-dimethylamino-3,6,10,12,12a-pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide; 2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-; Prestwick1_000753; C21H21ClN2O8; Ledermycin; 6-Demethyl-7-chlorotetracycline; Demethylchlortetracycline base; Demethylchlortetracycline; Spectrum5_000831; Demethylchlorotetracycline; Clortetrin; Demeclociclina; AC1NSQ1X; 8059-70-9; 2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; HSDB 3051; LS-187188; Demethylchlortetracycline (JAN); 2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-; CID5367858; (2E,4S,4aS,5aS,6S,12aS)-2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; CID2983; DMCT (antibiotic); KBio3_001355; CPD001496930; AC1O7G2H; D03680; Perciclina; 16204-02-7; Demeclocyclinum [INN-Latin]; UNII-5R5W9ICI6O; Demeclocycline Monohydrochloride; 6-Demethylchlortetracycline; AC1NSJXH; Deganol; 6-Demetil-7-clorotetraciclina; BSPBio_002135; Lopac0_000421; Demethylchlortetracyclin; Ledermycin hydrochloride; demeclocycline; NINDS_000863; Tri-demethylchlortetracycline; KBio2_003944; (2E,4S,4aS,5aS,6R,12aR)-2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; Chlortetracycline, 6-demethyl-; Demethylchlortetracyclinum; 7-Chloro-6-demethyltetracycline; 64-73-3 (mono-hydrochloride); CHEBI:4392; AC1L1EWT; LS-93855; [4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha)]-7-chloro-4-(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide; Spectrum_000896; Spectrum2_001132; DivK1c_000863; NCGC00162149-03; KBio2_006512; Demeclocycline (USP); Mexocine; Demeclociclina [INN-Spanish]; AC1NQXW1; BPBio1_000844; Diuciclin; Prestwick0_000753; KBio1_000863; EINECS 204-834-8; Tetracycline, 7-chloro-6-demethyl-; 6-Demethylchlorotetracycline; 2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, (4S,4aS,5aS,6S,12aS)-; Sumaclina; 2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, [4S-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.)]-; 6-Demethyl-7-chlortetracycline; Declomycin; IDI1_000863; BSPBio_000766; NCGC00015359-02; 6-Demetil-7-clorotetraciclina [Italian]; KBio2_001376; NCGC00162149-02; Prestwick2_000753; Bioterciclin; Demeclor; 64-73-3; Demeclocyclinum; Demetraclin; CID6603821; Methylchlorotetracycline; Spectrum4_000313; Lopac-D-6140; Prestwick3_000753; (2E)-2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; KBioSS_001376; NCGC00016290-01; SPBio_001023; 7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide; CAS-64-73-3; DB00618; 127-33-3    
Trade NameDeclomycin; Declostatin; Ledermycin    
CompanyPatheon Pharmaceuticals Inc.    
IndicationBacterial infectionsApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntibacterial Agents    
CAS NumberCAS 127-33-3
FormularC21H21ClN2O8    
PubChem Compound IDCID 5367858.    
PubChem Substance IDSID 10365209.    
SuperDrug ATC IDD06AA01;    
SuperDrug CAS ID000127333;    
Target30S ribosomal subunitBinder[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 050261 To Reference
Ref 2Detection of tetracycline resistance genes by PCR methods. Methods Mol Biol. 2004;268:3-13. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543